SOST and plasma cell myeloma: Additionally, myeloma cells modify the surrounding microenvironment and inhibit osteogenesis by direct secretion of Wnt antagonists, such as DKK-1, and by inducing the OB inhibitors, sclerostin, and activin, from mesenchymal cells and osteocytes [35,37].